Literature DB >> 16810678

Mutation of the SNF2 family member Chd2 affects mouse development and survival.

Concetta G A Marfella1, Yasuyuki Ohkawa, Andrew H Coles, David S Garlick, Stephen N Jones, Anthony N Imbalzano.   

Abstract

The chromodomain helicase DNA-binding domain (Chd) proteins belong to the SNF2-like family of ATPases that function in chromatin remodeling and assembly. These proteins are characterized by the presence of tandem chromodomains and are further subdivided based on the presence or absence of additional structural motifs. The Chd1-Chd2 subfamily is distinguished by the presence of a DNA-binding domain that recognizes AT-rich sequence. Currently, there are no reports addressing the function of the Chd2 family member. Embryonic stem cells containing a retroviral gene-trap inserted at the Chd2 locus were utilized to generate mice expressing a Chd2 protein lacking the DNA-binding domain. This mutation in Chd2 resulted in a general growth delay in homozygous mutants late in embryogenesis and in perinatal lethality. Animals heterozygous for the mutation showed decreased neonatal viability and increased susceptibility to non-neoplastic lesions affecting most primary organs. In particular, approximately 85% of the heterozygotes showed gross kidney abnormalities. Our results demonstrate that mutation of Chd2 dramatically affects mammalian development and long-term survival. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16810678     DOI: 10.1002/jcp.20718

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  48 in total

1.  Inhibitor of growth-4 promotes IkappaB promoter activation to suppress NF-kappaB signaling and innate immunity.

Authors:  Andrew H Coles; Hugh Gannon; Anna Cerny; Evelyn Kurt-Jones; Stephen N Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

Review 2.  The Chd family of chromatin remodelers.

Authors:  Concetta G A Marfella; Anthony N Imbalzano
Journal:  Mutat Res       Date:  2007-01-21       Impact factor: 2.433

3.  De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome.

Authors:  Arvid Suls; Johanna A Jaehn; Angela Kecskés; Yvonne Weber; Sarah Weckhuysen; Dana C Craiu; Aleksandra Siekierska; Tania Djémié; Tatiana Afrikanova; Padhraig Gormley; Sarah von Spiczak; Gerhard Kluger; Catrinel M Iliescu; Tiina Talvik; Inga Talvik; Cihan Meral; Hande S Caglayan; Beatriz G Giraldez; José Serratosa; Johannes R Lemke; Dorota Hoffman-Zacharska; Elzbieta Szczepanik; Nina Barisic; Vladimir Komarek; Helle Hjalgrim; Rikke S Møller; Tarja Linnankivi; Petia Dimova; Pasquale Striano; Federico Zara; Carla Marini; Renzo Guerrini; Christel Depienne; Stéphanie Baulac; Gregor Kuhlenbäumer; Alexander D Crawford; Anna-Elina Lehesjoki; Peter A M de Witte; Aarno Palotie; Holger Lerche; Camila V Esguerra; Peter De Jonghe; Ingo Helbig
Journal:  Am J Hum Genet       Date:  2013-10-24       Impact factor: 11.025

Review 4.  Architects of the genome: CHD dysfunction in cancer, developmental disorders and neurological syndromes.

Authors:  Wangzhi Li; Alea A Mills
Journal:  Epigenomics       Date:  2014       Impact factor: 4.778

Review 5.  Chromodomain helicase DNA-binding proteins in stem cells and human developmental diseases.

Authors:  Joseph A Micucci; Ethan D Sperry; Donna M Martin
Journal:  Stem Cells Dev       Date:  2015-02-25       Impact factor: 3.272

Review 6.  Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier.

Authors:  Akira Watanabe; Yasuhiro Yamada; Shinya Yamanaka
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-05       Impact factor: 6.237

7.  Autism-linked CHD gene expression patterns during development predict multi-organ disease phenotypes.

Authors:  Sahrunizam Kasah; Christopher Oddy; M Albert Basson
Journal:  J Anat       Date:  2018-10-02       Impact factor: 2.610

8.  A mutation in the mouse Chd2 chromatin remodeling enzyme results in a complex renal phenotype.

Authors:  Concetta G A Marfella; Nils Henninger; Scott E LeBlanc; Namrata Krishnan; David S Garlick; Lawrence B Holzman; Anthony N Imbalzano
Journal:  Kidney Blood Press Res       Date:  2009-01-14       Impact factor: 2.687

9.  Disruption of chromodomain helicase DNA binding protein 2 (CHD2) causes scoliosis.

Authors:  Shashikant Kulkarni; Prabakaran Nagarajan; Jonathan Wall; Diana J Donovan; Robert L Donell; Azra H Ligon; Sundaresan Venkatachalam; Bradley J Quade
Journal:  Am J Med Genet A       Date:  2008-05-01       Impact factor: 2.802

10.  Deletion of the Chd6 exon 12 affects motor coordination.

Authors:  Melissa J Lathrop; Lisa Chakrabarti; Jeremiah Eng; C Harker Rhodes; Thomas Lutz; Amelia Nieto; H Denny Liggitt; Sandra Warner; Jennifer Fields; Reinhard Stöger; Steven Fiering
Journal:  Mamm Genome       Date:  2010-01-29       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.